Who are SpotItEarly's investors?

SpotItEarly's investors include Hanaco Venture Capital.

How much funding has SpotItEarly raised?

SpotItEarly has disclosed $10K raised across 1 round.

Where is SpotItEarly headquartered?

SpotItEarly is headquartered in Englewood, US.

SpotItEarly

Englewood, US · Founded 2024 · Delaware corporation · 1 known investors

SpotitEarly develops an at-home, non-invasive cancer pre-screening test that analyzes volatile organic compounds in exhaled breath samples using trained canines combined with its LUCID AI platform of biosensors and data analysis. The multi-cancer early-detection product is offered to consumers via online subscription and has been validated in clinical trials with healthcare institutions in Israel and the U.S.

AI & Machine Learning Biotech Digital Health Healthtech

Founders & leadership

Roi OphirNamed on SEC filing

Shlomi MadarNamed on SEC filing

Shai LankryNamed on SEC filing

Assaf RufNamed on SEC filing

J. Leonard LichtenfeldNamed on SEC filing

Ariel Ben DayanNamed on SEC filing

Reef Einoch AmorPhD, Director of Chemical Analysis

Board

Alon Lifshitz in 𝕏Board directorCo-Founder and General Partner at Hanaco Venture Capital

Investors · 1

Hanaco Venture CapitalHerzliya · $2M – $20M

Reported raises · per SEC filings

Form D private placements

$10K disclosed across 1 round · 2025

▶$10KraisedAug 2025 · 1 investors · Biotechnology

Rule 506(c)

Officers, directors & promoters on the filing

Alon LifshitzDirector
Roi OphirDirector, Promoter
Shlomi MadarExecutive Officer, Director, Promoter
Shai LankryExecutive Officer, Director, Promoter
Assaf RufExecutive Officer
J. Leonard LichtenfeldExecutive Officer
Ariel Ben DayanDirector

Offering amount: $20M
Amount sold: $10K
Minimum investment: $100
First sale: Jul 2025
Incorporated: Corporation, Delaware, 2024
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Cancerresearchuk18 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.

Owlstonemedical16 shared keywordsOwlstone Medical develops Breath Biopsy products and services that analyze volatile organic compounds from breath and other sample types to enable non-invasive diagnostic tests for early disease detection and precision medicine. It works across cancer, respiratory, gastrointestinal, microbiome, and liver disease, serving researchers and healthcare applications.

Wagwalking14 shared keywordsWag! is a marketplace that connects pet owners with local pet caregivers for services including dog walking, drop-in visits, pet sitting, and boarding. The platform vets caregivers through background checks and provides real-time updates and communication tools for pet owners to monitor their pets during service.

Companies competing with SpotItEarly for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does SpotItEarly do?: SpotitEarly develops an at-home, non-invasive cancer pre-screening test that analyzes volatile organic compounds in exhaled breath samples using trained canines combined with its LUCID AI platform of biosensors and data analysis. The multi-cancer early-detection product is offered to consumers via online subscription and has been validated in clinical trials with healthcare institutions in Israel and the U.S.
Who are SpotItEarly's investors?: SpotItEarly's investors include Hanaco Venture Capital.
How much funding has SpotItEarly raised?: SpotItEarly has disclosed $10K raised across 1 round.
Where is SpotItEarly headquartered?: SpotItEarly is headquartered in Englewood, US.